Gísli Jenkins

2000–2025 年に発表

別表記
Gisli Jenkins
134
論文数
20,105
被引用数
61
h 指数
120
i10 指数

被引用数

Gísli Jenkins の年別被引用数1991 年: 被引用 1 件1993 年: 被引用 1 件1998 年: 被引用 1 件2001 年: 被引用 2 件2002 年: 被引用 8 件2003 年: 被引用 12 件2004 年: 被引用 8 件2005 年: 被引用 7 件2006 年: 被引用 11 件2007 年: 被引用 15 件2008 年: 被引用 20 件2009 年: 被引用 28 件2010 年: 被引用 46 件2011 年: 被引用 40 件2012 年: 被引用 72 件2013 年: 被引用 61 件2014 年: 被引用 67 件2015 年: 被引用 54 件2016 年: 被引用 59 件2017 年: 被引用 101 件2018 年: 被引用 111 件2019 年: 被引用 599 件2020 年: 被引用 906 件2021 年: 被引用 1,276 件2022 年: 被引用 1,122 件2023 年: 被引用 962 件2024 年: 被引用 1,273 件2025 年: 被引用 616 件2026 年: 被引用 13 件1992 年は被引用が無いため表示していません1994〜1997 年は被引用が無いため表示していません1999〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,075 件、この内訳の 20.4%中国: 引用元論文 1,099 件、この内訳の 10.8%イギリス: 引用元論文 1,018 件、この内訳の 10%ドイツ: 引用元論文 563 件、この内訳の 5.5%イタリア: 引用元論文 538 件、この内訳の 5.3%カナダ: 引用元論文 467 件、この内訳の 4.6%日本: 引用元論文 433 件、この内訳の 4.3%フランス: 引用元論文 367 件、この内訳の 3.6%オーストラリア: 引用元論文 302 件、この内訳の 3%スペイン: 引用元論文 268 件、この内訳の 2.6%オランダ: 引用元論文 258 件、この内訳の 2.5%韓国: 引用元論文 206 件、この内訳の 2%
0%20.4%その他 25.4%

分野

  • Medicine82.5%
  • Biochemistry, Genetics and Molecular Biology10.7%
  • Immunology and Microbiology2.4%
  • Engineering0.9%
  • Materials Science0.5%
  • Neuroscience0.4%
  • その他2.6%

トピック

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis17%
  • Long-Term Effects of COVID-195%
  • COVID-19 Clinical Research Studies3.9%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.8%
  • Systemic Sclerosis and Related Diseases3.3%
  • Sarcoidosis and Beryllium Toxicity Research2.7%
  • その他64.3%

共著者

全論文

検索で開く
  1. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Moisés Selman, William D. Travis, Simon Walsh, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2018 被引用: 4,100

  2. Emerging therapeutic opportunities for integrin inhibitors

    著者: , , , , - Nature Reviews Drug Discovery 2021 被引用: 554

  3. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 被引用: 1,444

  4. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew Davies, Anthony De Soyza, J R Geddes, William Greenhalf, Neil Greening, Liam G. Heaney, Simon Heller, Luke Howard, Joseph Jacob, Gísli Jenkins, Janet M. Lord, William D‐C Man, Gerry P McCann, Stefan Neubauer, Peter Openshaw, Joanna C. Porter, Matthew Rowland, J. T. Scott, Malcolm G. Semple, Sally Singh, David Thomas, Mark Toshner, Keir Lewis, Ryan S. Thwaites, Andrew Briggs, Annemarie B Docherty, S Kerr, Nazir Lone, Jennifer K Quint, Aziz Sheikh, Mathew Thorpe, Bang Zheng, James D. Chalmers, Ling‐Pei Ho, Alex Horsley, Michael Marks, K Poinasamy, Betty Raman, Ewen M. Harrison, Louise V. Wain, Christopher E. Brightling, Kathryn M. Abel, Huzaifa Adamali, Davies Adeloye, O Adeyemi, R Adrego, L A Aguilar Jimenez, Shazaad Ahmad, Nafees Haider, Rizwan Ahmed, N Ahwireng, Mark Ainsworth, B Al-Sheklly, A Alamoudi, Mohammad Ali, M Aljaroof, AM All, Louise Allan, R Allen, L. Allerton, Lynne Allsop, P. Almeida, Doris Altmann, Maria Alvarez Corral, S Amoils, Debra Anderson, Chrystalina A. Antoniades, G Arbane, A. Arias, Chérie Armour ほか 906 名 - The Lancet Respiratory Medicine 2022 被引用: 424

  5. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Janet M. Lord, Gerry P McCann, Stefan Neubauer, Peter Openshaw, Dhruv Parekh, Paul Pfeffer, Najib M. Rahman, Betty Raman, Matthew Richardson, Matthew Rowland, Malcolm G. Semple, Ajay M. Shah, Sally Singh, Aziz Sheikh, David Thomas, Mark Toshner, James D. Chalmers, Ling‐Pei Ho, Alex Horsley, Michael Marks, Krisnah Poinasamy, Louise V. Wain, Christopher E. Brightling, Kathryn M. Abel, Huzaifa Adamali, Davies Adeloye, O Adeyemi, Famous O. Adeyemi, Shazaad Ahmad, Rizwan Ahmed, Mark Ainsworth, B Al-Sheklly, Asma Khalid Alamoudi, M Aljaroof, Louise Allan, R Allen, A Alli, Doris Altmann, Debra Anderson, Michele Andrews, Adrienn Angyal, Chrystalina A. Antoniades, G Arbane, Chérie Armour, Natalie Armstrong, Lará Armstrong, H Arnold, David Arnold, Mark Ashworth, Andrew Ashworth, H Assefa-Kebede, Philip A. Atkin, H. Atkins, Amy Atkins, Raminder Aul, Cristina Avram, Rob Baggott, David Baguley, J. Kenneth Baillie, S. Bain, M Bakali, M Bakau, Eileen Baldry, David Baldwin, Clive Ballard, J. Bambrough, Ruth E Barker, Shaney Barratt, Fiona Barrett, D Basire ほか 680 名 - The Lancet Respiratory Medicine 2021 被引用: 659

  6. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

    著者: , , - The Lancet Respiratory Medicine 2020 被引用: 1,116

  7. An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis

    著者: , , , , , , , , , , , , , , , , - American Journal of Respiratory Cell and Molecular Biology 2017 被引用: 431

  8. Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theodore J. Iwashyna, Gísli Jenkins, Martin Kolb, Guy B. Marks, Peter J. Mazzone, J. Randall Moorman, Thomas M. Murphy, Terry L. Noah, Paul N. Reynolds, Dieter Riemann, Richard Russell, Aziz Sheikh, Giovanni Sotgiu, Erik R. Swenson, Rhonda D. Szczesniak, Ronald Szymusiak, Jean–Louis Teboul, Jean‐Louis Vincent - Annals of the American Thoracic Society 2018 被引用: 722

  9. Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tamera J. Corte, Ian Glaspole, Nicole Goh, Mark Holmes, M.A. Malouf, Francis Thien, Elizabeth Veitch, Benjamin Bondue, Caroline Dahlqvist, Antoine Froidure, Hans Slabbynck, Wim Wuyts, Claudia Cartagena Salinas, Rosa Feijoó Seoane, Victor D. Martínez, Roxana Maturana, Juana Pavie Gallegos, Andrés Rosenblüt, Rafael Silva, Alvaro Undurraga Pereira, Martina Doubková, Norbert Pauk, Martina Plačková, Martina Šterclová, Elisabeth Bendstrup, Saher Burhan Shaker, Ingrid Louise Titlestad, Stephan Budweiser, Christian Grohé, Dirk Koschel, Michael Kreuter, Antje Prasse, Michael Weber, Hubert Wirtz, Κατερίνα Αντωνίου, Zoe Daniil, Mina Gaga, Despoina Papakosta, Shinyu Izumi, Masaki Okamoto, Alfredo Guerreros Benavides, Carlos Barrera, Alejandro Manuel Peña Villalobos, Aranzazu Campo Ezquibela, José M. Cifrián, Estrella Fernández Fabrellas, Virginia Leiro, María Molina‐Molina, Asunción Nieto Barbero, Jacobo Sellarés, Claudia Valenzuela, Shih-Lung Cheng, Ping‐Hung Kuo, Kang‐Yun Lee, Chau‐Chyun Sheu, Hakan Günen, Nesrin Moğulkoç, Sibel Naycı, Huzaifa Adamali, Stephen Bianchi, Nazia Chaudhuri, Michael Gibbons, Simon P. Hart, Philip L. Molyneaux, Helen Parfrey, Gauri Saini, Lisa Spencer, Sarah Wiscombe, Danielle Antin‐Ozerkis, Rebecca Bascom ほか 152 名 - JAMA 2023 被引用: 127

  10. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation

    著者: , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2023 被引用: 178

  11. A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis

    著者: , , , , , , , , , , , , , , , , , , , - EBioMedicine 2022 被引用: 115

  12. Imperfect wound healing sets the stage for chronic diseases

    著者: , , , - Science 2024 被引用: 183

  13. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ayodeji Adegunsoye, Mary E. Strek, Margaret Neighbors, Xuting R. Sheng, Gunnar Guðmundsson, Vilmundur Guðnason, Hiroto Hatabu, David J. Lederer, Ani Manichaikul, John D. Newell, George O'connor, Victor E. Ortega, Hanfei Xu, Tasha E. Fingerlin, Yohan Bossé, Ke Hao, Philippe Joubert, David C. Nickle, Don D. Sin, Wim Timens, Dominic Furniss, Andrew P. Morris, Krina T. Zondervan, Ian P. Hall, Ian Sayers, Martin D. Tobin, Toby M. Maher, Michael H. Cho, Gary M. Hunninghake, David A. Schwartz, Brian L. Yaspan, Philip L. Molyneaux, Carlos Flores, Imre Noth, Gísli Jenkins, Louise V. Wain - American Journal of Respiratory and Critical Care Medicine 2019 被引用: 341

  14. Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ewen M. Harrison, Melissa Heightman, Toby Hillman, Alex Horsley, Linzy Houchen‐Wolloff, Ian Jarrold, Simon R. Johnson, Mark G. Jones, Fasihul Khan, Rod Lawson, Olivia C. Leavy, Nazir Lone, Michael Marks, Hamish McAuley, Puja Mehta, Dhruv Parekh, Karen Piper Hanley, Manuela Platé, John E. Pearl, Krisnah Poinasamy, Jennifer K Quint, Betty Raman, Matthew Richardson, Pilar Rivera‐Ortega, Laura Saunders, Ruth Saunders, Malcolm G. Semple, Marco Sereno, Aarti Shikotra, A. John Simpson, Amisha Singapuri, D Smith, Mark Spears, Lisa Spencer, Stefan Stanel, David Thickett, A. A. Roger Thompson, Mathew Thorpe, Simon Walsh, S Walker, Nicholas Weatherley, Mark C. Willingham, Jim M. Wild, Dan Wootton, Christopher E. Brightling, Ling‐Pei Ho, Louise V. Wain, Gísli Jenkins - American Journal of Respiratory and Critical Care Medicine 2022 被引用: 150

  15. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2017 被引用: 275

  16. Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial

    著者: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2024 被引用: 65

  17. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Declan P. O’Regan, Jonathan Fuld, Jonathan Weir‐McCall, Dhruv Parekh, Rick Steeds, Krisnah Poinasamy, Dan J Cuthbertson, Graham J. Kemp, Malcolm G. Semple, Alex Horsley, Chris Miller, Caitlin E. O’Brien, Ajay M. Shah, Amedeo Chiribiri, Olivia C. Leavy, Matthew Richardson, Omer Elneima, Hamish McAuley, Marco Sereno, Ruth Saunders, Linzy Houchen‐Wolloff, Neil Greening, Charlotte E. Bolton, Jeremy Brown, Gourab Choudhury, Nawar Diar Bakerly, Nicholas Easom, Carlos Echevarria, Michael Marks, John R. Hurst, Mark G. Jones, Dan Wootton, Trudie Chalder, Melanie J. Davies, Anthony De Soyza, John Geddes, William Greenhalf, Luke Howard, Joseph Jacob, William D‐C Man, Peter Openshaw, Joanna C. Porter, Matthew Rowland, J. T. Scott, Sally Singh, David Thomas, Mark Toshner, Keir Lewis, Liam G. Heaney, Ewen M. Harrison, Steven Kerr, Annemarie B Docherty, Nazir Lone, Jennifer K Quint, Aziz Sheikh, Bang Zheng, Gísli Jenkins, Eleanor Cox, Susan Francis, Mark Halling‐Brown, James D. Chalmers, John P. Greenwood, Sven Plein, Paul Hughes, A. A. Roger Thompson, Sarah Rowland‐Jones, James M Wild, Matthew Kelly, Thomas A. Treibel, Steven Bandula ほか 941 名 - The Lancet Respiratory Medicine 2023 被引用: 54

  18. Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diana Julie Leeming, Rachel C. Chambers, Pauline T. Lukey, Richard P. Marshall, Simon J. F. Macdonald, Gísli Jenkins, Robert J. Slack - Nature Communications 2020 被引用: 124

  19. Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis

    著者: , , , , , , , , , , - Thorax 2022 被引用: 123

  20. Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis

    著者: , , - Journal of Clinical Investigation 2023 被引用: 85

  21. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study

    著者: , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2015 被引用: 324

  22. COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts

    著者: , , , - Immunological Reviews 2021 被引用: 241

  23. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?

    著者: , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2018 被引用: 197

  24. Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort

    著者: , , , , , , , , , , , , , , , , - Respiratory Research 2019 被引用: 142